ARDMT

Field notes from the frontier of psychedelic neuroscience.
ARDMT tracks the latest peer-reviewed research, clinical trials, and policy developments at the intersection of psychedelics, neuropharmacology, and consciousness studies — from sigma-1 receptor mechanisms to spreading depolarisations, from clinical pipelines (DMT, psilocybin, MDMA, ibogaine) to regulatory shifts
Daily short-form Field Notes cover the most significant new findings as they're published. Weekly long-form deep dives unpack the consequential papers in detail.
S. Page — LLB, currently pursuing the MSc Psychedelics: Mind, Medicine and Culture at the University of Exeter. Years of ethnobotanical and cross-cultural fieldwork in Ecuador and Gabon, with formal research permissions from both nations.
The aim: rigorous, measured, accessible science journalism. Not advocacy, not pseudoscience. For researchers, clinicians, policy people, and the curious-and-careful general reader.
Full archive and reading list at ardmt.com.